Graves’ ophthalmopathy, also known as thyroid-associated ophthalmopathy and thyroid eye disease, is the most frequent extrathyroidal manifestation of Graves’ disease. The majority of Graves’ ophthalmopathy cases are caused due to Graves’ disease, and only a small percentage of these patients arise from other euthyroid or hypothyroid disorders.
As per DelveInsight’s estimates, as of 2022, ~2.4 million people were living with Graves’s ophthalmopathy across 7MM. The US contributed to the largest prevalent population of Graves’ ophthalmopathy, acquiring ~42% of the 7MM in 2022. Females constitute ~80% of the prevalent population. It tends to be more severe in me...
